Application of Cone Reconstruction for Neonatal Ebstein Anomaly or Tricuspid Valve Dysplasia Masanori Mizuno, MD, PhD, Takaya Hoashi, MD, PhD, Heima Sakaguchi, MD, PhD, Koji Kagisaki, MD, Masataka Kitano, MD, Kenichi Kurosaki, MD, Jun Yoshimatsu, MD, PhD, Isao Shiraishi, MD, PhD, Hajime Ichikawa, MD, PhD The Annals of Thoracic Surgery Volume 101, Issue 5, Pages 1811-1817 (May 2016) DOI: 10.1016/j.athoracsur.2015.11.029 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Selection of study cohort. (CS = central shunt; DA = ductus arteriosus; EA = Ebstein anomaly; TR = tricuspid regurgitation; TVD = tricuspid valve dysplasia.) The Annals of Thoracic Surgery 2016 101, 1811-1817DOI: (10.1016/j.athoracsur.2015.11.029) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Overall outcome of patients. (BVR = biventricular repair; EA = Ebstein anomaly; Op. = operation; TR = tricuspid regurgitation; TVD = tricuspid valve dysplasia.) The Annals of Thoracic Surgery 2016 101, 1811-1817DOI: (10.1016/j.athoracsur.2015.11.029) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Changes of tricuspid regurgitation flow velocity over time in the biventricular repair patients. The black circles indicate survivors after the operation, and the cross marks indicate deaths after the operation. (PA = pulmonary artery; TR = tricuspid regurgitation.) The Annals of Thoracic Surgery 2016 101, 1811-1817DOI: (10.1016/j.athoracsur.2015.11.029) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions